Methanol extract of Sanguisorba officinalis L. with cytotoxic activity against PC3 human prostate cancer cells

Molecular Medicine Reports

Volumn 6, Issue 3, 2012, Pages 670-674

  Choi, Eun Sun ^a   Kim, Jun Sung ^b   Kwon, Ki Han ^c   Kim, Hyng Seop ^a   Cho, Nam Pyo ^a   Cho, Sung Dae ^a  

^a Chonbuk National University   (South Korea)

^b Biterials Co Ltd   (South Korea)

^c Kwangju University   (South Korea)

Author keywords

Bax; Myeloid cell leukemia 1; Oligomerization; Prostate cancer; Sanguisorba officinalis L.

Indexed keywords

METHANOL; PLANT EXTRACT; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN MCL 1; SANGUISORBA OFFICINALIS EXTRACT; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL GROWTH; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE; OLIGOMERIZATION; PROSTATE CANCER; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SOLVENT EXTRACTION;

APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-X PROTEIN; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; HUMANS; MALE; METHANOL; PLANT EXTRACTS; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; SANGUISORBA;

EID: 84865185653     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.949     Document Type: Article

References (42)

1. Dayyani F, Gallick GE, Logothetis CJ and Corn PG: Novel therapies for metastatic castrate-resistant prostate cancer (Review). J Natl Cancer Inst 103: 1665-1675, 2011.
2. Eisermann K, Tandon S, Bazarov A, Brett A, Fraizer G and Piontkivska H: Evolutionary conservation of zinc finger transcription factor binding sites in promoters of genes co-expressed with WT1 in prostate cancer. BMC Genomics 9: 337, 2008.
3. Kaur M and Agarwal R: Transcription factors: molecular targets for prostate cancer intervention by phytochemicals (Review). Curr Cancer Drug Targets 7: 355-367, 2007. (Pubitemid 46849240)
4. Bardia A, Platz EA, Yegnasubramanian S, De Marzo AM and Nelson WG: Anti-inflammatory drugs, antioxidants, and prostate cancer prevention (Review). Curr Opin Pharmacol 9: 419-426, 2009.
5. Akgul C: Mcl-1 is a potential therapeutic target in multiple types of cancer (Review). Cell Mol Life Sci 66: 1326-1336, 2009.
6. Tang H, Shao H, Yu C and Hou J: Mcl-1 downregulation by YM155 contributes to its synergistic anti-tumor activities with ABT-263. Biochem Pharmacol 82: 1066-1072, 2011.
7. Zhang Z, Yang H, Wu G, Li Z, Song T and Li XQ: Probing the difference between BH3 groove of Mcl-1 and Bcl-2 protein: Implications for dual inhibitors design. Eur J Med Chem 46: 3909-3916, 2011.
8. Warr MR and Shore GC: Unique biology of Mcl-1: therapeutic opportunities in cancer (Review). Curr Mol Med 8: 138-147, 2008. (Pubitemid 351516833)
9. Takahashi H, Chen MC, Pham H, et al: Baicalein, a component of Scutellaria baicalensis, induces apoptosis by Mcl-1 downregulation in human pancreatic cancer cells. Biochim Biophys Acta 1813: 1465-1474, 2011.
10. Chen W, Bai L, Wang X, Xu S, Belinsky SA and Lin Y: Acquired activation of the Akt/cyclooxygenase-2/Mcl-1 pathway renders lung cancer cells resistant to apoptosis. Mol Pharmacol 77: 416-423, 2010.
11. Wei SH, Dong K, Lin F, et al: Inducing apoptosis and enhancing chemosensitivity to gemcitabine via RNA interference targeting Mcl-1 gene in pancreatic carcinoma cell. Cancer Chemother Pharmacol 62: 1055-1064, 2008.
12. Schulze-Bergkamen H, Fleischer B, Schuchmann M, et al: Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction. BMC Cancer 6: 232, 2006.
13. Guoan X, Hanning W, Kaiyun C and Hao L: Adenovirus-mediated siRNA targeting Mcl-1 gene increases radiosensitivity of pancreatic carcinoma cells in vitro and in vivo. Surgery 147: 553-561, 2010.
14. Bredholt T, Dimba EA, Hagland HR, et al: Camptothecin and khat (Catha edulis Forsk.) induced distinct cell death phenotypes involving modulation of c-FLIPL, Mcl-1, procaspase-8 and mitochondrial function in acute myeloid leukemia cell lines. Mol Cancer 8: 101, 2009.
15. Kim YI, Park SW, Choi IH, Lee JH, Woo HJ and Kim Y: Effect of Orostachys japonicus on cell growth and apoptosis in human hepatic stellate cell line LX2. Am J Chin Med 39: 601-613, 2011.
16. Lee NH, Lee MY, Lee JA, et al: Anti-asthmatic effect of Sanguisorba officinalis L. and potential role of heme oxygenase-1 in an ovalbumin-induced murine asthma model. Int J Mol Med 26: 201-208, 2010.
17. Cho JY, Yoo ES, Cha BC, Park HJ, Rhee MH and Han YN: The inhibitory effect of triterpenoid glycosides originating from Sanguisorba officinalis on tissue factor activity and the production of TNF-alpha. Planta Med 72: 1279-1284, 2006.
18. Goun EA, Petrichenko VM, Solodnikov SU, et al: Anticancer and antithrombin activity of Russian plants. J Ethnopharmacol 81: 337-342, 2002. (Pubitemid 34786318)
19. Ma Y, Zhang A, Shi Z, et al: A mitochondria-mediated apoptotic pathway induced by deoxynivalenol in human colon cancer cells. Toxicol In Vitro 26: 414-420, 2012.
20. Wang X, Zhang F, Yang L, et al: Ursolic acid inhibits proliferation and induces apoptosis of cancer cells in vitro and in vivo. J Biomed Biotechnol 2011: 419343, 2011.
21. Chen XR, Lu R, Dan HX, et al: Honokiol: a promising small molecular weight natural agent for the growth inhibition of oral squamous cell carcinoma cells. Int J Oral Sci 3: 34-42, 2011.
22. Wang Y, Deng L, Zhong H, Jiang X and Chen J: Natural plant extract tubeimoside I promotes apoptosis-mediated cell death in cultured human hepatoma (HepG2) cells. Biol Pharm Bull 34: 831-838, 2011.
23. Chun JY, Tummala R, Nadiminty N, et al: Andrographolide, a herbal medicine, inhibits interleukin-6 expression and suppresses prostate cancer cell growth. Genes Cancer 1: 868-876, 2010.
24. Lin YH, Chen KK and Chiu JH: Coprescription of Chinese herbal medicine and western medications among prostate cancer patients: a population-based study in Taiwan. Evid Based Complement Alternat Med 2012: 147015, 2012.
25. Wang Z, Loo WT, Wang N, Chow LW, Wang D, Han F, Zheng X and Chen JP: Effect of Sanguisorba officinalis L. on breast cancer growth and angiogenesis. Expert Opin Ther Targets 16 (Suppl 1): S79-S89, 2012.
26. Quinn BA, Dash R, Azab B, et al: Targeting Mcl-1 for the therapy of cancer (Review). Expert Opin Investig Drugs 20: 1397-1411, 2011.
27. Dash R, Azab B, Quinn BA, et al: Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicity. Proc Natl Acad Sci USA 108: 8785-8790, 2011.
28. Senft D, Berking C, Graf SA, Kammerbauer C, Ruzicka T and Besch R: Selective induction of cell death in melanoma cell lines through targeting of Mcl-1 and A1. PLoS One 7: e30821, 2012.
29. Shimazu T, Degenhardt K, Nur-E-Kamal A, et al: NBK/BIK antagonizes MCL-1 and BCL-XL and activates BAK-mediated apoptosis in response to protein synthesis inhibition. Genes Dev 21: 929-941, 2007. (Pubitemid 46625642)
30. Dewson G and Kluck RM: Mechanisms by which Bak and Bax permeabilise mitochondria during apoptosis. J Cell Sci 122: 2801-2808, 2009.
31. Kim H, Rafiuddin-Shah M, Tu HC, et al: Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Nat Cell Biol 8: 1348-1358, 2006. (Pubitemid 44835109)
32. Clohessy JG, Zhuang J, de Boer J, Gil-Gómez G and Brady HJ: Mcl-1 interacts with truncated Bid and inhibits its induction of cytochrome c release and its role in receptor-mediated apoptosis. J Biol Chem 281: 5750-5759, 2006. (Pubitemid 43847674)
33. Adams JM and Cory S: Bcl-2-regulated apoptosis: mechanism and therapeutic potential (Review). Curr Opin Immunol 19: 488-496, 2007. (Pubitemid 47487452)
34. Mitchell C, Yacoub A, Hossein H, et al: Inhibition of MCL-1 in breast cancer cells promotes cell death in vitro and in vivo. Cancer Biol Ther 10: 903-917, 2010.
35. Ménoret E, Gomez-Bougie P, Surget S, et al: Mcl-1(128-350) fragment induces apoptosis through direct interaction with Bax. FEBS Lett 584: 487-492, 2010.
36. Jiang CC, Wroblewski D, Yang F, Hersey P and Zhang XD: Human melanoma cells under endoplasmic reticulum stress are more susceptible to apoptosis induced by the BH3 mimetic obatoclax. Neoplasia 11: 945-955, 2009.
37. van Delft MF and Huang DC: How the Bcl-2 family of proteins interact to regulate apoptosis (Review). Cell Res 16: 203-213, 2006.
38. Adams JM: Ways of dying: multiple pathways to apoptosis. Genes Dev 17: 2481-2495, 2003.
39. Green DR and Kroemer G: The pathophysiology of mitochondrial cell death (Review). Science 305: 626-629, 2004. (Pubitemid 39006738)
40. Chu R, Upreti M, Ding WX, Yin XM and Chambers TC: Regulation of Bax by c-Jun NH2-terminal kinase and Bcl-xL in vinblastine-induced apoptosis. Biochem Pharmacol 78: 241-248, 2009.
41. Qanungo S, Das M, Haldar S and Basu A: Epigallocatechin- 3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells. Carcinogenesis 26: 958-967, 2005. (Pubitemid 41214325)
42. Zhao L, He F, Liu H, et al: Natural diterpenoid compound elevates expression of Bim protein, which interacts with antiapoptotic protein Bcl-2, converting it to proapoptotic Bax-like molecule. J Biol Chem 287: 1054-1065, 2012.